Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study
Domaines
| Origine | Fichiers produits par l'(les) auteur(s) |
|---|---|
| Licence |